Whitney Barham Ruifeng Guo Sean S Park Joerg Herrmann Haidong Dong Yiyi Yan
10.3389/fimmu.2020.561083
Front Immunol
2021 Feb 2;11:561083.
case report cytolytic t lymphocytes hyperprogression immune checkpoint inhibitors melanoma myocarditis
CC BY
https://pubmed.ncbi.nlm.nih.gov/33603731/
Immune Checkpoint Inhibitors / adverse effects Melanoma / complications Myocarditis / diagnosis Myocarditis / etiology
Immune Checkpoint Inhibitors / adverse effects Melanoma / complications Myocarditis / diagnosis Myocarditis / etiology Case Reports Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Aged Biomarkers Biomarkers, Tumor Biopsy Disease Management Disease Progression Disease Susceptibility Female Humans Immune Checkpoint Inhibitors / therapeutic use Melanoma / diagnosis Melanoma / drug therapy Melanoma / etiology Multimodal Imaging Myocarditis / therapy T-Lymphocyte Subsets / immunology T-Lymphocyte Subsets / metabolism T-Lymphocyte Subsets / pathology Biomarkers Biomarkers, Tumor Immune Checkpoint Inhibitors
PMC7884751
33603731
Case Report: Simultaneous Hyperprogression and Fulminant Myocarditis in a Patient With Advanced Melanoma Following Treatment With Immune Checkpoint Inhibitor Therapy
2021